.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
US Department of Justice
Merck
Chinese Patent Office
Healthtrust
Covington
Accenture
Fish and Richardson
Baxter
Queensland Health

Generated: June 27, 2017

DrugPatentWatch Database Preview

Galsulfase - Biologic Drug Details

« Back to Dashboard

Summary for Generic Name: galsulfase

Tradenames:1
Patents:4
Applicants:1
BLAs:1
Suppliers: see list1

Pharmacology for Drug: galsulfase

Ingredient-typealpha-Glucosidases
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Biomarin
NAGLAZYME
galsulfase
INJECTABLE; INJECTION1251170012005-05-318,277,830 ForSight Vision4, Inc. (Menlo Park, CA) de Juan, Jr.; Eugene (Menlo Park, CA), Alster; Yair (Menlo Park, CA), Farinas; Kathleen Cogan (Menlo Park, CA), Gifford, III; Hanson S. (Menlo Park, CA), MacFarlane; K. Angela (Menlo Park, CA), Reich; Cary J. (Menlo Park, CA), Barrett; Michael (Menlo Park, CA), Campbell; Randolph E. (Menlo Park, CA), Sutton; Douglas (Menlo Park, CA) ► SubscribeRXOrphansearch
Biomarin
NAGLAZYME
galsulfase
INJECTABLE; INJECTION1251170012005-05-318,399,006 Forsight Vision4, Inc. (Menlo Park, CA) de Juan, Jr.; Eugene (San Francisco, CA), Alster; Yair (Palo Alto, CA), Chamow; Steven M. (San Mateo, CA), Farinas; Kathleen Cogan (Los Altos, CA), Gifford, III; Hanson S. (Woodside, CA), Macfarlane; K. Angela (Woodside, CA), Reich; Cary J. (Los Gatos, CA), Barrett; Michael (Cupertino, CA), Campbell; Randolph E. (Redwood City, CA), George; Robert (San Jose, CA), Sutton; Douglas (Pacifica, CA) ► SubscribeRXOrphansearch
Biomarin
NAGLAZYME
galsulfase
INJECTABLE; INJECTION1251170012005-05-318,679,778 CMC Biologics A/S (Soeborg, Copenhagen, DK) Laustsen; Mads (Copenhagen, DK) ► SubscribeRXOrphansearch
Biomarin
NAGLAZYME
galsulfase
INJECTABLE; INJECTION1251170012005-05-318,729,241 Momenta Pharmaceuticals, Inc. (Cambridge, MA) Liu; Cuihua (Belmont, MA), Xu; Xiao-Jin (Jamaica Plain, MA), Dong; Shiming (North Reading, MA), Dellorusso; Guy (Milford, MA) ► SubscribeRXOrphansearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Deloitte
Chinese Patent Office
Baxter
McKesson
Medtronic
Boehringer Ingelheim
AstraZeneca
McKinsey
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot